Executive Summary
Generated July 30, 2026
Financial Services
Akur8
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Cooling
Activity
0 recorded changes in the last 90 days
Headquarters
Paris, France
Website
Overview
Akur8 is a Paris-based insurtech developing machine-learning-powered actuarial software for insurance pricing and reserving, serving more than 330 insurance customers across 40 countries. The company has raised over $186 million in total funding including a $120 million Series C led by One Peak, grew annual recurring revenue by more than 50% in 2026, acquired Matrisk AI to strengthen its pricing capabilities, and introduced new Rate Repo and Deploy modules to help insurers manage and operationalize pricing models across their organizations.
Strategic Connections
- AI Insurance Underwriting & Pricing: Akur8 provides machine-learning-powered actuarial pricing and reserving software used by over 330 insurance customers across 40 countries.
- Sixfold: Akur8 competes with Sixfold in AI-driven insurance decisioning, focusing on actuarial pricing and reserving versus Sixfold's underwriting workflow focus.
Strategic Risks
- Reliance on continued insurer trust in AI-driven pricing models amid growing regulatory scrutiny of algorithmic pricing fairness
- Competitive pressure from both established actuarial software vendors and newer AI-native entrants
Future Outlook
- Continued platform expansion via acquisitions (e.g., Matrisk AI) to build an end-to-end actuarial suite
- Growing international footprint as more insurers adopt AI-driven pricing and reserving tools to remain competitive
Sources
1 source, 44% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.